Vancomycin Intravenous

Rather than constituting an independent therapeutic drug class, "vancomycin intravenous" represents a specific route-based formulation and administration method of vancomycin, an antimicrobial belonging to the glycopeptide antibacterial class It exerts bactericidal action by inhibiting bacterial cell wall synthesis through high-affinity binding to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors Administered parenterally for systemic bioavailability, intravenous vancomycin s...

It exerts bactericidal action by inhibiting bacterial cell wall synthesis through high-affinity binding to the D-alanyl-D-alanine terminus of cell wall peptidoglycan precursors Administered parenterally for systemic bioavailability, intravenous vancomycin serves as a first-line therapy for severe or life-threatening Gram-positive infections, particularly those caused by methicillin-resistant *Staphylococcus aureus* (MRSA) Its primary therapeutic indications include bacteremia, infective endocard...